Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T30161 |
EN3356
AS N001,ASN-001 |
P450 | Metabolism |
EN3356 是一种可口服且具有选择性的类固醇 17-α- 羟化酶/C17,20 裂解酶(CYP17A1 或 CYP17)抑制剂,是一种非甾体类裂解酶选择性化合物,具有潜在的抗雄激素和抗肿瘤活性。 | |||
T63788 |
PCLX-001
|
Others | Others |
PCLX-001 is a small-molecule compound that acts as an orally active inhibitor of N-myristoyltransferase (NMT), specifically targeting NMT1 and NMT2 with IC50 values of 5 nM and 8 nM, respectively. This compound demonstrates anti-tumor effects and effectively inhibits the early signaling of B-cell receptor (BCR). Consequently, PCLX-001 is a valuable tool for researching B-cell malignancies [1] [2]. |